Patents by Inventor Mary Sheridan

Mary Sheridan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090209494
    Abstract: The present invention relates to 21-deoxymacbecin analogues that are useful, e.g. in the treatment of cancer, B-cell malignancies, malaria, fungal infection, diseases of the central nervous system and neurodegenerative diseases, diseases dependent on angiogenesis, autoimmune diseases or as a prophylactic pretreatment for cancer. The present invention also provides methods for the production of these compounds and their use in medicine, in particular in the treatment and or prophylaxis of cancer or B-cell malignancies.
    Type: Application
    Filed: December 22, 2006
    Publication date: August 20, 2009
    Inventors: Christine Janet Martin, Barrie Wilkinson, Sabine Gaisser, Ming-Oiang Zhang, Rose Mary Sheridan, Lesley Sarah Sheehan, Rachel Edith Lill, Mohammed Nur-E-Alam, William Alexander Vousden
  • Publication number: 20090176819
    Abstract: The present invention relates to novel 39-desmethoxy-39-methylrapamycin derivatives, methods for their production, and uses thereof. In a further aspect the present invention provides for the use of these 39-desmethoxy-39-methylrapamycin derivatives in the treatment of cancer and/or B-cell malignancies, the induction or maintenance of immunosuppression, the treatment of transplantation rejection, graft vs. host disease, autoimmune disorders, diseases of inflammation, vascular disease and fibrotic diseases, the stimulation of neuronal regeneration or the treatment of fungal infections.
    Type: Application
    Filed: November 19, 2008
    Publication date: July 9, 2009
    Applicants: Wyeth, Biotica Technology Limited
    Inventors: Barrie Wilkinson, Ming-Qiang Zhang, Rose Mary Sheridan
  • Publication number: 20080188511
    Abstract: The present invention relates to novel 39-desmethoxyrapamycin derivatives, methods for their production, and uses thereof. In a further aspect the present invention provides for the use of these 39-desmethoxyrapamycin derivatives in the treatment of cancer and/or B-cell malignancies, the induction or maintenance of immunosuppression, the treatment of transplantation rejection, graft vs. host disease, autoimmune disorders, diseases of inflammation, vascular disease and fibrotic diseases, the stimulation of neuronal regeneration or the treatment of fungal infections.
    Type: Application
    Filed: March 10, 2006
    Publication date: August 7, 2008
    Inventors: Christoph Hendrik Beckmann, Steven James Moss, Rose Mary Sheridan, Mingqiang Zhang, Barrie Wilkinson
  • Publication number: 20070184075
    Abstract: The present invention relates to medical uses of 39-desmethoxyrapamycin.
    Type: Application
    Filed: January 10, 2007
    Publication date: August 9, 2007
    Inventors: Mingqiang Zhang, Rose Mary Sheridan
  • Patent number: 7183289
    Abstract: The present invention relates to medical uses of 39-desmethoxyrapamycin.
    Type: Grant
    Filed: April 1, 2005
    Date of Patent: February 27, 2007
    Assignee: Biotica Technology Limited
    Inventors: Mingqiang Zhang, Rose Mary Sheridan